Douglas Burgoyne| VRx Pharmacy Services | USA | Antibiotics 2015 | Conference Series LLC
World Congress and Exhibition on Antibiotics September 14-16, 2015 Las Vegas, Nevada, USA
Scientific Talk On: Antibiotic stewardship – A role for managed care
Click here for Abstract and Biography: http://antibiotics.omicsgroup.com/abstract/2015/antibiotic-stewardship-a-role-for-managed-care
Dr Douglas Burgoyne is President of VRx Pharmacy Services, a pharmacy benefits management company, and was President of the Academy of Managed Care Pharmacy for 2012-2013, where he supported AMCP’s advocacy for managed care pharmacy principles at both state and federal levels, including presentations to the FDA. Dr Burgoyne is a founding member of UtahAWARE, an antibiotic resistance education program for Utah. In this role, he was influential in reducing inappropriate antibiotic use in pediatrics and adults through public awareness campaigns and physician education programs. Dr Burgoyne was a speaker at many appropriate-use meetings, including the CDC ‘Get Smart’ conference.
Antibiotic resistance (AMR) is a major global health concern according to WHO, CDC, and governments worldwide. Resistant infections kill 23,000 Americans annually. Upper respiratory tract infections (URTIs) are mostly viral (60%-90% non-bacterial) and self-limiting, yet inappropriate antibiotic prescription is common, especially in primary care, which drives AMR. Even for bacterial URTIs antibiotics offer little or no immediate benefit; patients still need symptomatic therapy, which should always be utilized to minimize inappropriate use of antibiotics. The Global Respiratory Infection Partnership (GRIP) was initiated in 2011 to promote rational antibiotic stewardship for URTIs by focusing on symptomatic therapies and reducing inappropriate antibiotic use. The organization has developed the ‘5P’ framework to promote change and appropriate management of URTIs. Most antibiotics are low-cost drugs and provide little financial incentive for improving rational prescribing, compared to the expense of biologics and other novel drugs. However, there is an overwhelming public health imperative for reducing antibiotic resistance and promoting responsible antibiotic stewardship. What can be done? Strategies are required that increase access to symptomatic therapies and incentivize their use, including over-the-counter products. Different reimbursement approaches could also be considered. Ways to achieve these goals will be discussed, including potential roles for primary care and pharmacies. Managed Care can also influence patient education, especially concerning misperceptions about antibiotic use. Conclusions Managed Care could potentially reduce inappropriate antibiotic prescribing and increase use of symptomatic therapies to reduce AMR. This would support the goals of GRIP for responsible antibiotic stewardship and promotion of symptomatic therapies for URTIs.
Conference Series LLC (3000+ Global Events): conferenceseries.com
Global Medical Conferences: conferenceseries.com
Global Nursing Conferences: nursingconference.com
Global Pharmaceutical Conferences: pharmaceuticalconferences.com
Global Cancer Conferences: cancersummit.org
Global Diabetes Conferences: diabetesexpo.com
Global Dental Conferences: dentalcongress.com
700+ Open Access Journals: omicsonline.org